|
HS Code |
865730 |
| Product Name | Fmoc-Lys(Dnp)-OH |
| Chemical Formula | C28H28N4O7 |
| Molecular Weight | 532.55 g/mol |
| Appearance | yellow powder |
| Cas Number | 111755-19-4 |
| Purity | ≥98% |
| Solubility | soluble in DMF, DMSO |
| Storage Temperature | 2-8°C |
| Protected Groups | Fmoc (N-term), Dnp (ε-amino) |
| Usage | peptide synthesis |
| Synonyms | Fmoc-L-Lys(Dnp)-OH |
| Optical Activity | [α]20/D +28° (c=1, DMF) |
| Handling | handle in a dry environment |
| Sensitivity | moisture sensitive |
| Shipping | ambient temperature |
As an accredited Fmoc-Lys(Dnp)-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Fmoc-Lys(Dnp)-OH is supplied in a 1-gram amber glass vial, sealed, with tamper-evident cap and detailed labeling. |
| Shipping | Fmoc-Lys(Dnp)-OH is shipped in tightly sealed, moisture-resistant containers at controlled room temperature. The packaging complies with regulations for chemical transport, ensuring protection from light and contamination. Accompanying documentation includes safety and handling instructions. Expedited shipping options are available to minimize transit time and preserve product stability and integrity. |
| Storage | **Fmoc-Lys(Dnp)-OH** should be stored in a cool, dry, and well-ventilated area, ideally at 2–8°C, protected from light and moisture. Keep the container tightly closed when not in use. Avoid exposure to incompatible substances, such as strong acids or oxidizers. Store under inert gas (e.g., nitrogen) if possible to prevent degradation and maintain its chemical integrity. |
Applications of Fmoc-Lys(Dnp)-OH in Industrial ManufacturingFmoc-Lys(Dnp)-OH serves as a functional protected amino acid derivative, widely leveraged in advanced peptide synthesis and high-value biochemical production. Our manufacturing partners in the life sciences and chemical sectors integrate this building block into several critical downstream processes, delivering specialized products for pharmaceuticals, diagnostics, and research reagents. 1. Custom Peptide Synthesis for Therapeutic DevelopmentPeptide contract manufacturers and pharmaceutical labs utilize this derivative in solid-phase synthesis processes to introduce Dnp-protected lysine sites into linear and cyclic peptide sequences. It supports selective deprotection strategies required for therapies targeting oncogenic pathways and metabolic diseases. The product enables predictable conjugation and site-specific labeling, facilitating downstream purification and clinical candidate validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fluorescent and Chromogenic Peptide Labeling ReagentsBiotech manufacturers employ this material to introduce Dnp-tagged lysine residues for site-specific chromogenic labeling. The Dnp moiety supports downstream analytical applications, particularly in platforms employing FRET (Förster resonance energy transfer) and absorbance-based peptide quantification. Users control Dnp exposure precisely during synthesis for consistent labeling indices in diagnostic peptide kits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Protease Substrate and Inhibitor Design for Enzymology ResearchAcademic research centers and industrial life science R&D entities rely on Dnp-protected lysine modules for the synthesis of mechanistic probes and competitive inhibitors. These building blocks allow for the generation of highly specific fluorogenic and chromogenic substrates, supporting enzymatic activity analysis and structure-function studies. The controlled Dnp protection level ensures reliable cleavage tracking and quantification in kinetic assays. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Solid-Phase Peptide Array SynthesisDiagnostic and biochip companies integrate this protected amino acid into multi-dimensional peptide array production workflows. The Dnp protecting group enables positional deprotection for localized modification, required in mapping antibody binding and enzyme interaction events. Synthesis protocols benefit from the group’s chemical robustness, supporting high-density array fabrication at scale with reproducible spot chemistry. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Fmoc-Lys(Dnp)-OH prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Stepping into the plant early in the morning, the familiar smell of raw amino acid starting materials already drifts from the synthesis bays. We don’t just process chemicals; we create custom-built molecular tools meant for those who shape the world of peptides. With Fmoc-Lys(Dnp)-OH, we provide a product that supports the design of innovative peptides, tailored quality from a manufacturer’s bench. This isn’t a story handed down from a distributor or a reseller; it comes straight from those who run the reactors, test purity, and fine-tune the final yields.
Fmoc-Lys(Dnp)-OH catches attention among peptide chemists for a good reason. It is lysine, a key amino acid, but protected and modified at both ends for solid-phase synthesis needs. The N-terminal bears the fluorenylmethoxycarbonyl (Fmoc) group. This group keeps the alpha-amine tamed until it is time to extend the chain. The ε-amine, sitting further down the flexible side chain lysine is known for, carries the dinitrophenyl (Dnp) group. This protective Dnp group is a deliberate choice: it is especially resistant to the usual cleavage steps, offering stability during complex coupling sequences, and acting as a chromophore that marks its presence by UV absorption.
On our line, we raise the purity bar. Typical offerings meet a purity of at least 98 percent, with both single and double-protected side chains rigorously controlled by HPLC, NMR, and mass spectrometry. We keep residual solvents and byproducts below thresholds laid out in international guidelines, not just to tick off regulatory boxes, but because we’ve seen what contaminants can do to automated peptide synthesizers or those precious pilot batches.
Years ago, peptide chemists often faced the issue of side chain deprotection cross-contaminating their final products, or unwanted branching at the lysine residue. The Dnp group on this molecule solves those problems in most synthetic pathways. Fmoc-Lys(Dnp)-OH lets scientists incorporate a protected lysine that stays inert under typical deprotection conditions used for Fmoc removal. Researchers can build their peptide sequence knowing the side chain amine will only react when they decide. If a project involves post-assembly transformations—say, conjugating a label or crosslinker only at a specific position—the Dnp-protected lysine sits ready until a selective strategy strips it away.
We’ve seen project leads rely on this strategy for preparing enzyme substrates, site-specific ligation handles, or toxins where modification control means the difference between meaningful data and wasted time. The Dnp group isn’t just about avoidance; its yellow hue absorbs light near 360 nm, making it a tracking marker for both QC teams and basic researchers looking for visibility in purification or analytical assays. In our experience, this built-in UV activity saves troubleshooting steps weeks into an otherwise invisible process.
Comparison separates the chosen tool from the rest of the bin. Most peptide synthesis today starts with either Fmoc-Lys(Boc)-OH or Fmoc-Lys(Mtt)-OH. Boc and Mtt groups shield the ε-amino group as well, but each brings its own quirks. Boc protection strips off with strong acid: it doesn’t handle TFA flux as well, and in longer peptides, especially with acid-sensitive sequences or tags, researchers see yield drop or impurities spike. Mtt gives milder deprotection, but can bleed off in acidic washes meant for entirely different parts of the molecule, and Mtt’s removal can produce side products that lurk under mass spec thresholds but show up in bioassays.
Years of feedback have shown us the value of offering a Dnp option. The Dnp group likes to stay put during most Fmoc/tBu strategies. If you’re working with sequences demanding the maximum orthogonality—no crosstalk between protection groups—Dnp’s distinct removal chemistry helps you design multi-step modifications. Direct Dnp removal by concentrated alkali or sodium dithionite offers control that Boc and Mtt don’t. While this means Dnp isn’t the first choice for automated, “one-pot” syntheses, it opens avenues for selective labeling and branching that chemistry built around Boc or Mtt can’t match.
We don’t see Dnp as better or worse than Boc and Mtt; rather, it is a specialist’s choice. When customers call, their first concern is usually: “Will this group withstand my conditions up to the point where I actually want it to come off, and not before?” Dnp gives a “yes” more often than not, especially in routes calling for orthogonal strategies or monitoring by UV.
Producing Fmoc-Lys(Dnp)-OH in our facility goes beyond following a checklist. It’s a blend of chemistry, experience, and real-world troubleshooting. We run batch reactions under nitrogen to guard against oxidation, prepare and handle the Dnp chloride in darkened hood setups to preserve protection integrity, and check for over-Dnp’d byproducts by TLC before the product advances. Our technicians perform solid-phase filtration and controlled crystallization with an eye on minimizing Dnp hydrolysis or Fmoc loss. Each batch gets confirmed by mass and HPLC, yes, but also by looking for the distinct yellow color and peak intensity under 360 nm lamps—a tradition as much as quality control.
We keep close watch on the moisture levels and glassware used, since traces of acid or water can disrupt protection patterns. Every so often, we’ll see a stubborn side product turn up, sometimes trace nitrated byproducts. The team catches these early, rerouting the stream to a secondary purification system before blending makes them hard to remove. These little details don’t always make it to the order forms, but they carve the difference between easy solubility, sharp batch reproducibility, and the “unknowns” that haunt peptide synthesis troubleshooting later.
Fmoc-Lys(Dnp)-OH leaves our dock and heads into university departments, pharmaceutical labs, and diagnostic companies. From our conversations and troubleshooting calls, it’s clear the molecule fits most often into three categories. First, researchers planning a peptide that demands precise, late-stage modifications pick Fmoc-Lys(Dnp)-OH to insert a handle for dye labeling or conjugation. The product lets them call the shots on position and sequence, thanks to Dnp’s orthogonality.
Second, those tracking their syntheses by UV rather than more expensive HPLC or MS methods benefit from the Dnp chromophore. Throughout purification, those yellow bands or peaks indicate progress without costly runs. This saves money and, as batch losses shrink, helps keep projects within deadlines.
Third, we see interest rising from those working with branched peptides or cyclic structures, especially in work related to enzyme-substrate studies or cell-penetrating peptides. Dnp’s ability to stay inert until the very end—whether under Fmoc cleavage, TFA, or mild acid—means one less unknown in the sometimes chaotic world of complex peptide assemblies.
No batch has ever shown one-hundred percent yield or trouble-free progress. Experience running this chemistry teaches patience and vigilance. We’ve learned to watch for Dnp migration or double labeling, and set up our processes to minimize heat and light exposure—which can leave behind nitroarene byproducts that complicate downstream purification. Handling Dnp-protected compounds carries occupational safety concerns; staff wear filtered masks and monitor airborne Dnp levels in our vented hoods to keep exposure in check.
Quality assurance doesn’t end at HPLC purity readout. Many of the big peptide players expect full documentation, including residual solvent analysis and heavy-metal screening. We’ve expanded our QC program beyond the basics, since a few micrograms difference can mean batch scrapping when constructing clinical-grade peptides. Some partners send material back for co-validation, running our product head-to-head with alternatives in their own synthesis routines. These collaborations keep us honest and push us to document not just “meets specification,” but how each batch behaves under real-world coupling, deprotection, and long-term storage.
One ongoing difficulty has surfaced: ensuring that the product reaching a bench somewhere overseas is actually from our batch. We occasionally hear of researchers receiving material labeled “Fmoc-Lys(Dnp)-OH” that performs poorly or contains unknown peaks, sourced from traders or gray-market suppliers. Years ago, we began labeling each lot with a unique spectral fingerprint and initiated direct-seal packaging to help distinguish genuine product.
We urge direct purchase through a trusted channel, not for marketing's sake but to ensure the material matches its certificate and behaves predictably. One failed synthesis can cost weeks or months, and it’s our responsibility as a manufacturer to minimize risk down the supply chain.
Shelf stability in Fmoc-Lys(Dnp)-OH can’t be overstated. Kept cool and away from light, it lasts for months without degradation. Occasional clients, especially those in humid regions, ask about caking or hydrolysis. What we’ve noticed is that a dry, amber glass bottle with a desiccant improves both storage time and batch-to-batch reproducibility. Exposure to air and moisture accelerates breakdown not just of Fmoc or Dnp, but also creates weak spots in the crystalline matrix, making later solubilization harder. Our facility packages each lot in amber bottles under nitrogen flow, based on tests that show clearly improved recovery for samples kept this way.
Disruptions in the global chemical supply network—raw material shortages, unpredictable fuel costs, and regulatory shifts—affect price and availability. It takes constant communication with primary reagent suppliers to lock down pure Dnp chloride and Fmoc reagents. Over the last few years, we increased local buffer stocks and diversified cold storage facilities, anticipating interruptions. Our focus isn’t just on producing a chemical, but on ensuring those who rely on it for critical research never miss a milestone due to a missed delivery or quality lapse.
Feedback from repeat customers shapes how we handle complaints or requests for documentation. Most want not only a batch certificate, but also records of the actual synthesis run, proof of UV absorbance, and trace impurity profiles. Instead of treating this as a burden, we learn from it. Our tracking system lets us tie each container of Fmoc-Lys(Dnp)-OH back not only to its raw ingredients but to the date and conditions of its final packaging. This attention to production and supply detail matters to everyone aiming for publishable, reproducible science.
As the chemical industry changes, so do expectations around safety, traceability, and transparency. We see first-hand how adherence to ethical standards and rigorous documentation underpins everything sold under our roof. We base our work on experience and evidence—the two things that matter from the bench to the boardroom. Each process step and analytical result connects to the expertise accumulated over years of batch runs, troubleshooting, and collaboration with end users.
No shortcuts appear in our process, and our records are open to third-party audit by customers or regulatory partners. From our end, this not only supports compliance for those seeking clinical peptide status, but offers peace of mind across the chain: what leaves our facility matches exactly what the documentation promises.
Direct feedback from labs fuels every improvement, large and small. Reports of increased solubility problems with certain solvents led us to refine our drying and particle sizing procedures. A spike in demand from diagnostic kit manufacturers prompted us to retool production scheduling, reducing wait times and improving on-time fulfillment rates.
Some of the most useful enhancements sprang from unplanned conversations with returning clients. For example, peptide chemists working on cell-permeable peptides with Dnp-protected lysine shared data that let us spot a trend: shorter reaction times for Dnp removal when paired with specific deprotection agents. This real-world evidence feeds into our process notes, and we share insights back with the community, reinforcing the cycle of improvement and trust.
Peptide synthesis doesn’t stand still. As methods evolve—automated platforms, click-chemistry conjugations, or mixed protection sequences—Fmoc-Lys(Dnp)-OH adapts with them. Our role as a manufacturer is not only to provide a reliable building block, but to stay close to the edge of new developments. We monitor the literature, attend conferences, and keep the lines open with partners testing the limits of what protected lysine can do.
Whenever someone asks us, “Why choose Fmoc-Lys(Dnp)-OH made by a manufacturer?” the answer ties back to process, experience, and the desire to be more than a supplier. Our factory delivers more than product; it brings a set of lessons learned, hurdles overcome, and a commitment to quality recognized by those who demand control and reliability in the lab.
Every vial and drum that leaves our production floor builds on the lessons learned from years of hands-on chemistry and troubleshooting. We make Fmoc-Lys(Dnp)-OH not as faceless intermediaries but as creators forging the bridge from raw inputs to sophisticated research solutions. Every crystal, every test run, every document aims for one thing: that your next sequence, your next assay, your next insight reaches further, with chemistry you can trust not because it’s commercially available, but because it’s made with care, expertise, and an unmatched attention to real-world needs.